Stay updated on HELIOS-B: Vutrisiran in TTR Amyloidosis Cardiomyopathy Clinical Trial
Sign up to get notified when there's something new on the HELIOS-B: Vutrisiran in TTR Amyloidosis Cardiomyopathy Clinical Trial page.

Latest updates to the HELIOS-B: Vutrisiran in TTR Amyloidosis Cardiomyopathy Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedA new revision label (v3.3.3) was added and the HHS Vulnerability Disclosure link along with the v3.3.2 revision note were removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedNew version 3.3.2 was added on 2025-11-20 with an updated Study Status; the prior revision v3.2.0 is removed.SummaryDifference0.2%

- Check47 days agoChange DetectedRemoved the government funding lapse disclaimer that used to appear on the page; its removal does not affect the study data, status details, or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check55 days agoChange DetectedRecord History was updated with a new 2025-11-05 entry adding Contacts/Locations and Study Status (version 66), and an older 2025-10-21 entry was removed.SummaryDifference0.2%

- Check69 days agoChange DetectedNew record versions 63–65 appear, showing updated Study Status and a Results Submission event, along with related QC notes. These entries reflect the latest updates to the trial's record history.SummaryDifference0.1%

- Check91 days agoChange DetectedNew study status sections and a v3.2.0 revision are added, along with a government-operating-status notice; the old v3.1.0 revision is removed.SummaryDifference11%

Stay in the know with updates to HELIOS-B: Vutrisiran in TTR Amyloidosis Cardiomyopathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HELIOS-B: Vutrisiran in TTR Amyloidosis Cardiomyopathy Clinical Trial page.